New Developments in Global Cardiac Assist Devices Market 2015-2020 Oct.2016 | Page 2

Global Cardiac Assist Devices Market According to the report "Cardiac Assist Devices Market by Type {Ventricular Assist Devices (VAD), Intra-Aortic Balloon Pumps (IABP) & Total Artificial Heart (TAH)}, and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2015 – 2020)", published by Market Data Forecast, the global market is projected to reach $1988.8 Million by 2020, at a CAGR of 8.43% from 2015 to 2020. For full report refer to http://www.marketdataforecast.com/market-reports/globalcardiac-assist-devices-market-25/ Cardiac assist devices are the electromechanical devices which are used for assisting cardiac circulation which replace the function of heart either partially or completely. These devices are different from the artificial pacemakers as they are mainly used to keep patients alive until a donor heart can be found for transplantation or in certain cases support the heart circulation over a period of years. Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-cardiac-assist-devices-market-25/request-sample Demand for these cardiac assist devices is expected to increase after the launch of novel technologically advanced products. Key factors for the growth of the market are availability of efficient devices, rise in incidences of cardiovascular devices, technological advancements and increase in aging population. Patients with severe heart complications are unable to get donor hearts due to their shortage, hence increasing the demand for cardiac assist devices. Segmentation by Type:    Ventricular assist devices (VAD)  Right ventricular assist device (RVAD)  Left ventricular assist device (LVAD)  Bi- ventricular assist device (Bi-VAD)  External ventricular assist devices Intra-aortic Balloon pumps (IABP) Total artificial heart (TAH) Major players in the market are Teleflex Incorporated, Berlin Heart GmbH, Abiomed, Inc., HeartWare International, Jarvik Heart, Inc. and Terumo Corporation. BiVacor Pty Ltd, Braile Biomedica Ltd., Calon Cardio-Technology Ltd., CardiacAssist, Inc., CardioBridge GmbH, Carmat SAS, Cleveland Heart, Inc., CorAssist Cardiovascular Ltd., Evaheart Medical USA, Inc., Leviticus Cardio Ltd., MyoCardioCare, Inc., SynCardia Systems, Inc. and Windmill Cardiovascular Systems, Inc. TABLE OF CONTENTS 1. Introduction 1.1 Market Definition [phone] | www.marketdataforecast.com | [email protected]